Presenting “Identifying 6x More Cancer Patients with Cachexia in a Privacy Preserving Manner” at SCWD 2022

Venue: Faculdade de Medicina da Universidade de Lisboa (FMUL), Lisbon, Portugal

Leading researchers and oncologists, Dr. Barry Laird and Dr. Richard Skipworth, have been invited to present the results of our collaboration titled, Identifying Cancer Patients with Cachexia at Scale by Leveraging Self-Supervised Natural Language Processing and Predictive Models on Unstructured Data in Patients’ Electronic Health Records, at the annual Sarcopenia, Cachexia & Wasting Disorders (SCWD) conference.

Abstract: International Classification of Diseases (ICD) codes often cannot characterize patients with diseases like Cachexia accurately due to high probability of miscoding, while manual inspection of patient records is costly and slow. An AI driven workflow is presented which leverages structured, discrete values and unstructured textual data from Electronic Health Records, to automatically identify cancer patients who have Cachexia, especially those who might be miscoded or undiagnosed.

Request Poster

—

The 15^th international Conference of the Society on Cachexia, Sarcopenia & Muscle Wasting, will take place on the 24^th – 26^th June 2022 in Lisbon under the guidance of Chairs of the SCWD, Prof. Stefan Anker (Berlin, Germany), and Prof. John Morley (Saint Louis, USA).

Presenters

Dr. Barry Laird

Physician
Edinburgh Cancer Centre & St. Columba’s Hospice

Dr. Richard Skipworth

Surgeon
Royal Infirmary of Edinburgh